Globus Medical Q3 2021 Earnings Report
Key Takeaways
Globus Medical reported a 6.3% increase in worldwide net sales, reaching $229.7 million. GAAP net income increased by 6.8% to $47.2 million, with a GAAP diluted EPS of $0.45 and a non-GAAP diluted EPS of $0.50. The company reaffirmed its full-year 2021 guidance of $950 million in net sales and non-GAAP diluted earnings per share of $2.00.
Worldwide net sales increased by 6.3% compared to Q3 2020, reaching $229.7 million.
GAAP net income for the quarter was $47.2 million, representing 20.6% of net sales.
GAAP diluted EPS was $0.45, and non-GAAP diluted EPS was $0.50.
The company reaffirmed its full-year 2021 guidance of $950 million in net sales and non-GAAP diluted earnings per share of $2.00.
Globus Medical
Globus Medical
Globus Medical Revenue by Segment
Globus Medical Revenue by Geographic Location
Forward Guidance
The Company today reaffirmed its full year 2021 guidance of $950 million in net sales and non-GAAP diluted earnings per share of $2.00.
Revenue & Expenses
Visualization of income flow from segment revenue to net income